Oscar Health Inc. (OSCR) Misses Q1 EPS by 12c; reaffirms guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Nasdaq futures slip on chip weakness; S&P 500 holds gains
- Massive market rotation raises question: Is the sell-AI trade here to stay?
- Goldman sees major AI and data center policy implications from ‘blue tsunami’
- Nvidia chips stockpile in Hong Kong awaits China import approval - report
- Goldman says this FX trade is the best hedge for the AI drawdown
Tweet
Share
E-mail
Get Alerts OSCR Hot Sheet
Join SI Premium – FREE
Oscar Health Inc. (NYSE: OSCR) reported Q1 EPS of ($0.18), $0.12 worse than the analyst estimate of ($0.06). Revenue for the quarter came in at $1.47 billion versus the consensus estimate of $1.27 billion.
Oscar is reaffirming its full year 2023 outlook across all metrics as provided in its financial results press release dated February 9, 2023, including anticipated MLR range between 82% and 84%, and Adjusted EBITDA1 loss of ($175) million to ($75) million.
For earnings history and earnings-related data on Oscar Health Inc. (OSCR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Privia Health Group, Inc. (PRVA) Tops Q3 EPS by 12c ; Offers Guidance
- Filana Therapeutics, Inc. (FLNA) Tops Q3 EPS by 3c
- Appian Corporation (APPN) Tops Q3 EPS by 18c; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
